ID   K1C16_HUMAN             Reviewed;         473 AA.
AC   P08779; A8K488; P30654; Q16402; Q9UBG8;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-JUN-2023, entry version 218.
DE   RecName: Full=Keratin, type I cytoskeletal 16;
DE   AltName: Full=Cytokeratin-16;
DE            Short=CK-16;
DE   AltName: Full=Keratin-16;
DE            Short=K16;
GN   Name=KRT16; Synonyms=KRT16A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2431270; DOI=10.1128/mcb.6.2.539-548.1986;
RA   Raychaudhury A., Marchuk D., Lindhurst M., Fuchs E.;
RT   "Three tightly linked genes encoding human type I keratins: conservation of
RT   sequence in the 5'-untranslated leader and 5'-upstream regions of
RT   coexpressed keratin genes.";
RL   Mol. Cell. Biol. 6:539-548(1986).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=2451124; DOI=10.1128/mcb.8.2.722-736.1988;
RA   Rosenberg M., Raychaudhury A., Shows T.B., le Beau M.M., Fuchs E.;
RT   "A group of type I keratin genes on human chromosome 17: characterization
RT   and expression.";
RL   Mol. Cell. Biol. 8:722-736(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   PubMed=7487986; DOI=10.1006/bbrc.1995.2495;
RA   Paladini R.D., Takahashi K., Gant T.M., Coulombe P.A.;
RT   "cDNA cloning and bacterial expression of the human type I keratin 16.";
RL   Biochem. Biophys. Res. Commun. 215:517-523(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Smith F.J.D., Fisher M.P., Healy E., Rees J.L., McKusick V.A.,
RA   Bonifas J.M., Epstein E.H. Jr., Tan E., Uitto J., McLean W.H.I.;
RT   "Cloning of multiple keratin 16 genes: genotype-phenotype correlation and
RT   protein expression studies in pachyonychia congenita type 1 and focal
RT   palmoplantar keratoderma.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 118-134, AND VARIANT PC1 PRO-132.
RX   PubMed=7539673; DOI=10.1038/ng0395-273;
RA   McLean W.H.I., Rugg E.L., Lunny D.P., Morley S.M., Lane E.B., Swensson O.,
RA   Dopping-Hepenstal P.J.C., Griffiths W.A.D., Eady R.A.J., Higgins C.,
RA   Navsaria H.A., Leigh I.M., Strachan T., Kunkeler L., Munro C.S.;
RT   "Keratin 16 and keratin 17 mutations cause pachyonychia congenita.";
RL   Nat. Genet. 9:273-278(1995).
RN   [9]
RP   PROTEIN SEQUENCE OF 137-148; 178-195 AND 264-283.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [10]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::aid-prot212>3.0.co;2-h;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line protein
RT   expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [11]
RP   INTERACTION WITH TCHP.
RX   PubMed=15731013; DOI=10.1242/jcs.01667;
RA   Nishizawa M., Izawa I., Inoko A., Hayashi Y., Nagata K., Yokoyama T.,
RA   Usukura J., Inagaki M.;
RT   "Identification of trichoplein, a novel keratin filament-binding protein.";
RL   J. Cell Sci. 118:1081-1090(2005).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=26758872; DOI=10.1093/hmg/ddw001;
RA   Allen E.H., Courtney D.G., Atkinson S.D., Moore J.E., Mairs L.,
RA   Poulsen E.T., Schiroli D., Maurizi E., Cole C., Hickerson R.P., James J.,
RA   Murgatroyd H., Smith F.J., MacEwen C., Enghild J.J., Nesbit M.A.,
RA   Leslie Pedrioli D.M., McLean W.H., Moore C.B.;
RT   "Keratin 12 missense mutation induces the unfolded protein response and
RT   apoptosis in Meesmann epithelial corneal dystrophy.";
RL   Hum. Mol. Genet. 25:1176-1191(2016).
RN   [16]
RP   VARIANTS FNEPPK1 SER-125 AND CYS-127.
RX   PubMed=8595410; DOI=10.1093/hmg/4.10.1875;
RA   Shamsheer M.K., Navsaria H.A., Stevens H.P., Ratnavel R.C., Purkis P.E.,
RA   McLean W.H.I., Cook L.J., Griffiths W.A.D., Geschmeissner S., Spurr N.,
RA   Leigh I.M.;
RT   "Novel mutations in keratin 16 gene underly focal nonepidermolytic
RT   palmoplantar keratoderma (NEPPK) in two families.";
RL   Hum. Mol. Genet. 4:1875-1881(1995).
RN   [17]
RP   VARIANTS PC1 PRO-122 AND PRO-127.
RX   PubMed=10606845; DOI=10.1046/j.1365-2133.1999.03198.x;
RA   Smith F.J.D., Del Monaco M., Steijlen P.M., Munro C.S., Morvay M.,
RA   Coleman C.M., Rietveld F.J.R., Uitto J., McLean W.H.I.;
RT   "Novel proline substitution mutations in keratin 16 in two cases of
RT   pachyonychia congenita type 1.";
RL   Br. J. Dermatol. 141:1010-1016(1999).
RN   [18]
RP   VARIANT PC1 SER-130 DEL.
RX   PubMed=10521820;
RX   DOI=10.1002/(sici)1097-0223(199910)19:10<941::aid-pd663>3.3.co;2-n;
RA   Smith F.J., McKusick V.A., Nielsen K., Pfendner E., Uitto J.,
RA   McLean W.H.I.;
RT   "Cloning of multiple keratin 16 genes facilitates prenatal diagnosis of
RT   pachyonychia congenita type 1.";
RL   Prenat. Diagn. 19:941-946(1999).
RN   [19]
RP   VARIANT PC1 ARG-124.
RX   PubMed=10839714; DOI=10.1034/j.1600-0625.2000.009003170.x;
RA   Smith F.J., Fisher M.P., Healy E., Rees J.L., Bonifas J.M.,
RA   Epstein E.H. Jr., Tan E.M., Uitto J., McLean W.H.I.;
RT   "Novel keratin 16 mutations and protein expression studies in pachyonychia
RT   congenita type 1 and focal palmoplantar keratoderma.";
RL   Exp. Dermatol. 9:170-177(2000).
RN   [20]
RP   VARIANT 104-GLY--ALA-107 DEL.
RX   PubMed=10844556; DOI=10.1046/j.1523-1747.2000.00983.x;
RA   Terrinoni A., Puddu P., Didona B., De Laurenzi V., Candi E., Smith F.J.,
RA   McLean W.H.I., Melino G.;
RT   "A mutation in the V1 domain of K16 is responsible for unilateral
RT   palmoplantar verrucous nevus.";
RL   J. Invest. Dermatol. 114:1136-1140(2000).
RN   [21]
RP   VARIANT PC1 ASN-354.
RX   PubMed=11359398; DOI=10.1046/j.1365-2133.2001.04199.x;
RA   Connors J.B., Rahil A.K., Smith F.J.D., McLean W.H.I., Milstone L.M.;
RT   "Delayed-onset pachyonychia congenita associated with a novel mutation in
RT   the central 2B domain of keratin 16.";
RL   Br. J. Dermatol. 144:1058-1062(2001).
RN   [22]
RP   VARIANTS PC1 THR-121 AND PC1 GLN-128.
RX   PubMed=11886499; DOI=10.1046/j.0022-202x.2001.01565.x;
RA   Terrinoni A., Smith F.J.D., Didona B., Canzona F., Paradisi M., Huber M.,
RA   Hohl D., David A., Verloes A., Leigh I.M., Munro C.S., Melino G.,
RA   McLean W.H.I.;
RT   "Novel and recurrent mutations in the genes encoding keratins K6a, K16 and
RT   K17 in 13 cases of pachyonychia congenita.";
RL   J. Invest. Dermatol. 117:1391-1396(2001).
RN   [23]
RP   VARIANTS PC1 PRO-124; HIS-124; ASP-125; SER-125; CYS-127 AND PRO-132.
RX   PubMed=16250206; DOI=10.1111/j.1087-0024.2005.10204.x;
RA   Smith F.J., Liao H., Cassidy A.J., Stewart A., Hamill K.J., Wood P.,
RA   Joval I., van Steensel M.A., Bjoerck E., Callif-Daley F., Pals G.,
RA   Collins P., Leachman S.A., Munro C.S., McLean W.H.;
RT   "The genetic basis of pachyonychia congenita.";
RL   J. Investig. Dermatol. Symp. Proc. 10:21-30(2005).
RN   [24]
RP   VARIANTS PC1 SER-125; PRO-127 AND GLN-128.
RX   PubMed=17719747; DOI=10.1016/j.jdermsci.2007.07.003;
RA   Liao H., Sayers J.M., Wilson N.J., Irvine A.D., Mellerio J.E., Baselga E.,
RA   Bayliss S.J., Uliana V., Fimiani M., Lane E.B., McLean W.H., Leachman S.A.,
RA   Smith F.J.;
RT   "A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia
RT   congenita.";
RL   J. Dermatol. Sci. 48:199-205(2007).
RN   [25]
RP   VARIANTS PC1 SER-125; PRO-127 AND PRO-132.
RX   PubMed=21326300; DOI=10.1038/jid.2011.20;
RA   Wilson N.J., Leachman S.A., Hansen C.D., McMullan A.C., Milstone L.M.,
RA   Schwartz M.E., McLean W.H., Hull P.R., Smith F.J.;
RT   "A large mutational study in pachyonychia congenita.";
RL   J. Invest. Dermatol. 131:1018-1024(2011).
RN   [26]
RP   VARIANTS PC1 SER-125; ASP-125; PRO-127 AND CYS-127.
RX   PubMed=21160496; DOI=10.1038/jid.2010.373;
RA   Fu T., Leachman S.A., Wilson N.J., Smith F.J., Schwartz M.E., Tang J.Y.;
RT   "Genotype-phenotype correlations among pachyonychia congenita patients with
RT   K16 mutations.";
RL   J. Invest. Dermatol. 131:1025-1028(2011).
RN   [27]
RP   VARIANT PC1 GLY-125.
RX   PubMed=22668561; DOI=10.1684/ejd.2012.1773;
RA   Du Z.F., Xu C.M., Zhao Y., Liu W.T., Chen X.L., Chen C.Y., Fang H.,
RA   Ke H.P., Zhang X.N.;
RT   "Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese
RT   pachyonychia congenita pedigrees with fissured tongue or diffuse plantar
RT   keratoderma.";
RL   Eur. J. Dermatol. 22:476-480(2012).
RN   [28]
RP   VARIANT PC1 PRO-421.
RX   PubMed=24118415; DOI=10.1111/exd.12262;
RA   Paris F., Hurtado C., Azon A., Aguado L., Vizmanos J.L.;
RT   "A new KRT16 mutation associated with a phenotype of pachyonychia
RT   congenita.";
RL   Exp. Dermatol. 22:838-839(2013).
CC   -!- FUNCTION: Epidermis-specific type I keratin that plays a key role in
CC       skin. Acts as a regulator of innate immunity in response to skin
CC       barrier breach: required for some inflammatory checkpoint for the skin
CC       barrier maintenance. {ECO:0000250|UniProtKB:Q9Z2K1}.
CC   -!- SUBUNIT: Heterodimer of a type I and a type II keratin. KRT16
CC       associates with KRT6 isomers (KRT6A or KRT6B) (By similarity).
CC       Interacts with TCHP (PubMed:15731013). Interacts with TRADD (By
CC       similarity). {ECO:0000250|UniProtKB:Q9Z2K1,
CC       ECO:0000269|PubMed:15731013}.
CC   -!- INTERACTION:
CC       P08779; A2BDD9: AMOT; NbExp=3; IntAct=EBI-356410, EBI-17286414;
CC       P08779; P53365: ARFIP2; NbExp=3; IntAct=EBI-356410, EBI-638194;
CC       P08779; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-356410, EBI-8643161;
CC       P08779; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-356410, EBI-747505;
CC       P08779; Q9H257-2: CARD9; NbExp=3; IntAct=EBI-356410, EBI-11530605;
CC       P08779; Q8IYE0: CCDC146; NbExp=3; IntAct=EBI-356410, EBI-10749669;
CC       P08779; Q96LX7-5: CCDC17; NbExp=3; IntAct=EBI-356410, EBI-12165781;
CC       P08779; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-356410, EBI-10175300;
CC       P08779; P24863: CCNC; NbExp=3; IntAct=EBI-356410, EBI-395261;
CC       P08779; Q07002: CDK18; NbExp=3; IntAct=EBI-356410, EBI-746238;
CC       P08779; Q9UIA0: CYTH4; NbExp=3; IntAct=EBI-356410, EBI-11521003;
CC       P08779; Q7L775: EPM2AIP1; NbExp=3; IntAct=EBI-356410, EBI-6255981;
CC       P08779; O95995: GAS8; NbExp=3; IntAct=EBI-356410, EBI-1052570;
CC       P08779; P50151: GNG10; NbExp=3; IntAct=EBI-356410, EBI-10211741;
CC       P08779; O14964: HGS; NbExp=3; IntAct=EBI-356410, EBI-740220;
CC       P08779; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-356410, EBI-14069005;
CC       P08779; Q9NSK0: KLC4; NbExp=3; IntAct=EBI-356410, EBI-949319;
CC       P08779; P04264: KRT1; NbExp=3; IntAct=EBI-356410, EBI-298429;
CC       P08779; P35908: KRT2; NbExp=3; IntAct=EBI-356410, EBI-1247312;
CC       P08779; P12035: KRT3; NbExp=3; IntAct=EBI-356410, EBI-2430095;
CC       P08779; P19013: KRT4; NbExp=3; IntAct=EBI-356410, EBI-2371606;
CC       P08779; P13647: KRT5; NbExp=3; IntAct=EBI-356410, EBI-702187;
CC       P08779; P02538: KRT6A; NbExp=3; IntAct=EBI-356410, EBI-702198;
CC       P08779; P48668: KRT6C; NbExp=3; IntAct=EBI-356410, EBI-2564105;
CC       P08779; Q3SY84: KRT71; NbExp=3; IntAct=EBI-356410, EBI-2952676;
CC       P08779; Q14CN4: KRT72; NbExp=3; IntAct=EBI-356410, EBI-1221280;
CC       P08779; Q86Y46-2: KRT73; NbExp=3; IntAct=EBI-356410, EBI-12039441;
CC       P08779; Q7RTS7: KRT74; NbExp=3; IntAct=EBI-356410, EBI-968660;
CC       P08779; Q01546: KRT76; NbExp=3; IntAct=EBI-356410, EBI-2952745;
CC       P08779; Q8N1N4: KRT78; NbExp=3; IntAct=EBI-356410, EBI-1056564;
CC       P08779; Q5XKE5: KRT79; NbExp=3; IntAct=EBI-356410, EBI-2514135;
CC       P08779; P05787: KRT8; NbExp=3; IntAct=EBI-356410, EBI-297852;
CC       P08779; Q6KB66-2: KRT80; NbExp=3; IntAct=EBI-356410, EBI-11999246;
CC       P08779; Q14533: KRT81; NbExp=3; IntAct=EBI-356410, EBI-739648;
CC       P08779; P78385: KRT83; NbExp=3; IntAct=EBI-356410, EBI-10221390;
CC       P08779; P78386: KRT85; NbExp=3; IntAct=EBI-356410, EBI-1049371;
CC       P08779; O43790: KRT86; NbExp=3; IntAct=EBI-356410, EBI-9996498;
CC       P08779; P25800: LMO1; NbExp=3; IntAct=EBI-356410, EBI-8639312;
CC       P08779; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-356410, EBI-739832;
CC       P08779; O95983-2: MBD3; NbExp=3; IntAct=EBI-356410, EBI-11978579;
CC       P08779; Q16512: PKN1; NbExp=3; IntAct=EBI-356410, EBI-602382;
CC       P08779; Q9UGP5-2: POLL; NbExp=3; IntAct=EBI-356410, EBI-10320765;
CC       P08779; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-356410, EBI-2557469;
CC       P08779; P54646: PRKAA2; NbExp=3; IntAct=EBI-356410, EBI-1383852;
CC       P08779; P41219: PRPH; NbExp=3; IntAct=EBI-356410, EBI-752074;
CC       P08779; Q3MIT2: PUS10; NbExp=3; IntAct=EBI-356410, EBI-11983583;
CC       P08779; Q9C0C4: SEMA4C; NbExp=3; IntAct=EBI-356410, EBI-10303490;
CC       P08779; Q96ES7: SGF29; NbExp=3; IntAct=EBI-356410, EBI-743117;
CC       P08779; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-356410, EBI-358489;
CC       P08779; Q969G3: SMARCE1; NbExp=3; IntAct=EBI-356410, EBI-455078;
CC       P08779; O95295: SNAPIN; NbExp=3; IntAct=EBI-356410, EBI-296723;
CC       P08779; Q9BT92: TCHP; NbExp=3; IntAct=EBI-356410, EBI-740781;
CC       P08779; Q99816: TSG101; NbExp=3; IntAct=EBI-356410, EBI-346882;
CC       P08779; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-356410, EBI-9090990;
CC       P08779; Q8N3L3: TXLNB; NbExp=3; IntAct=EBI-356410, EBI-6116822;
CC       P08779; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-356410, EBI-739895;
CC   -!- TISSUE SPECIFICITY: Expressed in the corneal epithelium (at protein
CC       level). {ECO:0000269|PubMed:26758872}.
CC   -!- MASS SPECTROMETRY: Mass=50924.66; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:11840567};
CC   -!- DISEASE: Pachyonychia congenita 1 (PC1) [MIM:167200]: An autosomal
CC       dominant ectodermal dysplasia characterized by hypertrophic nail
CC       dystrophy resulting in onchyogryposis (thickening and increase in
CC       curvature of the nail), palmoplantar keratoderma, follicular
CC       hyperkeratosis, and oral leukokeratosis. Hyperhidrosis of the hands and
CC       feet is usually present. {ECO:0000269|PubMed:10521820,
CC       ECO:0000269|PubMed:10606845, ECO:0000269|PubMed:10839714,
CC       ECO:0000269|PubMed:11359398, ECO:0000269|PubMed:11886499,
CC       ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:17719747,
CC       ECO:0000269|PubMed:21160496, ECO:0000269|PubMed:21326300,
CC       ECO:0000269|PubMed:22668561, ECO:0000269|PubMed:24118415,
CC       ECO:0000269|PubMed:7539673}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Keratoderma, palmoplantar, non-epidermolytic, focal 1
CC       (FNEPPK1) [MIM:613000]: A dermatological disorder characterized by non-
CC       epidermolytic palmoplantar keratoderma limited to the pressure points
CC       on the balls of the feet, with later mild involvement on the palms.
CC       Oral, genital and follicular keratotic lesions are often present.
CC       {ECO:0000269|PubMed:8595410}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological
CC       situations such as metaplasias and carcinomas of the uterine cervix and
CC       in psoriasis vulgaris.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin, I (acidic) and II (neutral to basic) (40-55 and 56-70 kDa,
CC       respectively).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M28439; AAA59460.1; -; Genomic_DNA.
DR   EMBL; M28432; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28433; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28434; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28435; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28436; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28437; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; M28438; AAA59460.1; JOINED; Genomic_DNA.
DR   EMBL; S79867; AAB35421.1; -; mRNA.
DR   EMBL; AF061809; AAD15829.1; -; Genomic_DNA.
DR   EMBL; AF061812; AAC99326.1; -; mRNA.
DR   EMBL; AK290853; BAF83542.1; -; mRNA.
DR   EMBL; CH471152; EAW60749.1; -; Genomic_DNA.
DR   EMBL; BC039169; AAH39169.1; -; mRNA.
DR   EMBL; S78514; AAB34564.1; -; Genomic_DNA.
DR   CCDS; CCDS11401.1; -.
DR   PIR; A33652; A33652.
DR   PIR; JC4313; JC4313.
DR   RefSeq; NP_005548.2; NM_005557.3.
DR   AlphaFoldDB; P08779; -.
DR   SMR; P08779; -.
DR   BioGRID; 110066; 161.
DR   IntAct; P08779; 83.
DR   MINT; P08779; -.
DR   STRING; 9606.ENSP00000301653; -.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   GlyGen; P08779; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P08779; -.
DR   PhosphoSitePlus; P08779; -.
DR   SwissPalm; P08779; -.
DR   BioMuta; KRT16; -.
DR   DMDM; 23503075; -.
DR   jPOST; P08779; -.
DR   MassIVE; P08779; -.
DR   PaxDb; P08779; -.
DR   PeptideAtlas; P08779; -.
DR   PRIDE; P08779; -.
DR   ProteomicsDB; 52166; -.
DR   Antibodypedia; 3602; 734 antibodies from 37 providers.
DR   DNASU; 3868; -.
DR   Ensembl; ENST00000301653.9; ENSP00000301653.3; ENSG00000186832.9.
DR   GeneID; 3868; -.
DR   KEGG; hsa:3868; -.
DR   MANE-Select; ENST00000301653.9; ENSP00000301653.3; NM_005557.4; NP_005548.2.
DR   UCSC; uc002hxg.5; human.
DR   AGR; HGNC:6423; -.
DR   CTD; 3868; -.
DR   DisGeNET; 3868; -.
DR   GeneCards; KRT16; -.
DR   GeneReviews; KRT16; -.
DR   HGNC; HGNC:6423; KRT16.
DR   HPA; ENSG00000186832; Tissue enhanced (cervix, esophagus, skin, vagina).
DR   MalaCards; KRT16; -.
DR   MIM; 148067; gene.
DR   MIM; 167200; phenotype.
DR   MIM; 613000; phenotype.
DR   neXtProt; NX_P08779; -.
DR   OpenTargets; ENSG00000186832; -.
DR   Orphanet; 2199; Epidermolytic palmoplantar keratoderma.
DR   Orphanet; 448264; Isolated focal non-epidermolytic palmoplantar keratoderma.
DR   Orphanet; 2309; Pachyonychia congenita.
DR   PharmGKB; PA30210; -.
DR   VEuPathDB; HostDB:ENSG00000186832; -.
DR   eggNOG; ENOG502QTM6; Eukaryota.
DR   GeneTree; ENSGT00940000154602; -.
DR   HOGENOM; CLU_012560_8_3_1; -.
DR   InParanoid; P08779; -.
DR   OMA; GHQTRPI; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; P08779; -.
DR   TreeFam; TF332742; -.
DR   PathwayCommons; P08779; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   SignaLink; P08779; -.
DR   SIGNOR; P08779; -.
DR   BioGRID-ORCS; 3868; 24 hits in 1147 CRISPR screens.
DR   ChiTaRS; KRT16; human.
DR   GeneWiki; Keratin_16; -.
DR   GenomeRNAi; 3868; -.
DR   Pharos; P08779; Tbio.
DR   PRO; PR:P08779; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P08779; protein.
DR   Bgee; ENSG00000186832; Expressed in gingival epithelium and 112 other tissues.
DR   ExpressionAtlas; P08779; baseline and differential.
DR   Genevisible; P08779; HS.
DR   GO; GO:0001533; C:cornified envelope; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; NAS:UniProtKB.
DR   GO; GO:0045095; C:keratin filament; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0042633; P:hair cycle; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0031424; P:keratinization; ISS:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0051546; P:keratinocyte migration; ISS:UniProtKB.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; ISS:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF105; KERATIN, TYPE I CYTOSKELETAL 16; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Direct protein sequencing; Disease variant;
KW   Ectodermal dysplasia; Intermediate filament; Keratin;
KW   Palmoplantar keratoderma; Reference proteome.
FT   CHAIN           1..473
FT                   /note="Keratin, type I cytoskeletal 16"
FT                   /id="PRO_0000063662"
FT   DOMAIN          117..428
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..116
FT                   /note="Head"
FT   REGION          117..152
FT                   /note="Coil 1A"
FT   REGION          153..170
FT                   /note="Linker 1"
FT   REGION          171..262
FT                   /note="Coil 1B"
FT   REGION          263..285
FT                   /note="Linker 12"
FT   REGION          286..424
FT                   /note="Coil 2"
FT   REGION          425..473
FT                   /note="Tail"
FT   REGION          428..473
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         104..107
FT                   /note="Missing (rare variant; found as somatic mutation in
FT                   a patient with localized epidermolytic hyperkeratosis in
FT                   the right palm and the right sole; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:10844556"
FT                   /id="VAR_012854"
FT   VARIANT         121
FT                   /note="M -> T (in PC1; dbSNP:rs28928894)"
FT                   /evidence="ECO:0000269|PubMed:11886499"
FT                   /id="VAR_017065"
FT   VARIANT         122
FT                   /note="Q -> P (in PC1; dbSNP:rs59349773)"
FT                   /evidence="ECO:0000269|PubMed:10606845"
FT                   /id="VAR_012855"
FT   VARIANT         124
FT                   /note="L -> H (in PC1; dbSNP:rs58293603)"
FT                   /evidence="ECO:0000269|PubMed:16250206"
FT                   /id="VAR_072436"
FT   VARIANT         124
FT                   /note="L -> P (in PC1; dbSNP:rs58293603)"
FT                   /evidence="ECO:0000269|PubMed:16250206"
FT                   /id="VAR_072437"
FT   VARIANT         124
FT                   /note="L -> R (in PC1; dbSNP:rs58293603)"
FT                   /evidence="ECO:0000269|PubMed:10839714"
FT                   /id="VAR_013837"
FT   VARIANT         125
FT                   /note="N -> D (in PC1; dbSNP:rs58608173)"
FT                   /evidence="ECO:0000269|PubMed:16250206,
FT                   ECO:0000269|PubMed:21160496"
FT                   /id="VAR_072438"
FT   VARIANT         125
FT                   /note="N -> G (in PC1; requires 2 nucleotide substitutions;
FT                   dbSNP:rs587777717)"
FT                   /evidence="ECO:0000269|PubMed:22668561"
FT                   /id="VAR_072439"
FT   VARIANT         125
FT                   /note="N -> S (in FNEPPK1 and PC1; dbSNP:rs60723330)"
FT                   /evidence="ECO:0000269|PubMed:16250206,
FT                   ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:21160496,
FT                   ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:8595410"
FT                   /id="VAR_009183"
FT   VARIANT         127
FT                   /note="R -> C (in FNEPPK1 and PC1; dbSNP:rs59856285)"
FT                   /evidence="ECO:0000269|PubMed:16250206,
FT                   ECO:0000269|PubMed:21160496, ECO:0000269|PubMed:8595410"
FT                   /id="VAR_009184"
FT   VARIANT         127
FT                   /note="R -> P (in PC1; dbSNP:rs57424749)"
FT                   /evidence="ECO:0000269|PubMed:10606845,
FT                   ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:21160496,
FT                   ECO:0000269|PubMed:21326300"
FT                   /id="VAR_012856"
FT   VARIANT         128
FT                   /note="L -> Q (in PC1; dbSNP:rs28928895)"
FT                   /evidence="ECO:0000269|PubMed:11886499,
FT                   ECO:0000269|PubMed:17719747"
FT                   /id="VAR_017066"
FT   VARIANT         130
FT                   /note="Missing (in PC1)"
FT                   /evidence="ECO:0000269|PubMed:10521820"
FT                   /id="VAR_035440"
FT   VARIANT         132
FT                   /note="L -> P (in PC1; dbSNP:rs60944949)"
FT                   /evidence="ECO:0000269|PubMed:16250206,
FT                   ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:7539673"
FT                   /id="VAR_003846"
FT   VARIANT         354
FT                   /note="K -> N (in PC1; late onset; dbSNP:rs59328451)"
FT                   /evidence="ECO:0000269|PubMed:11359398"
FT                   /id="VAR_017067"
FT   VARIANT         421
FT                   /note="L -> P (in PC1)"
FT                   /evidence="ECO:0000269|PubMed:24118415"
FT                   /id="VAR_072440"
FT   CONFLICT        2
FT                   /note="T -> A (in Ref. 3; AAB35421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        26
FT                   /note="G -> A (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        38
FT                   /note="G -> A (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41..43
FT                   /note="RAP -> PA (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        49..50
FT                   /note="GL -> A (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        187..189
FT                   /note="QPI -> HAL (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        208..211
FT                   /note="HELA -> ARTG (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        352
FT                   /note="S -> R (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        452..460
FT                   /note="SRQTRPILK -> AVRPGPSS (in Ref. 1; AAA59460)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   473 AA;  51268 MW;  BA8CE9F4716A88A4 CRC64;
     MTTCSRQFTS SSSMKGSCGI GGGIGGGSSR ISSVLAGGSC RAPSTYGGGL SVSSRFSSGG
     ACGLGGGYGG GFSSSSSFGS GFGGGYGGGL GAGFGGGLGA GFGGGFAGGD GLLVGSEKVT
     MQNLNDRLAS YLDKVRALEE ANADLEVKIR DWYQRQRPSE IKDYSPYFKT IEDLRNKIIA
     ATIENAQPIL QIDNARLAAD DFRTKYEHEL ALRQTVEADV NGLRRVLDEL TLARTDLEMQ
     IEGLKEELAY LRKNHEEEML ALRGQTGGDV NVEMDAAPGV DLSRILNEMR DQYEQMAEKN
     RRDAETWFLS KTEELNKEVA SNSELVQSSR SEVTELRRVL QGLEIELQSQ LSMKASLENS
     LEETKGRYCM QLSQIQGLIG SVEEQLAQLR CEMEQQSQEY QILLDVKTRL EQEIATYRRL
     LEGEDAHLSS QQASGQSYSS REVFTSSSSS SSRQTRPILK EQSSSSFSQG QSS
//
